12 Health Care Stocks Moving In Tuesday's Intraday Session

Benzinga·05/13/2025 17:06:46

Listen to the news

Gainers

HCW Biologics (NASDAQ:HCWB) stock increased by 173.1% to $14.23 during Tuesday's regular session. The market value of their outstanding shares is at $15.9 million.
Xilio Therapeutics (NASDAQ:XLO) shares increased by 40.75% to $1.03. The market value of their outstanding shares is at $53.2 million. As per the news, the Q1 earnings report came out 3 days ago.
CNS Pharma (NASDAQ:CNSP) shares rose 38.01% to $1.67. The market value of their outstanding shares is at $4.9 million.
Humacyte (NASDAQ:HUMA) stock moved upwards by 33.33% to $1.76. The market value of their outstanding shares is at $273.0 million. The company's, Q1 earnings came out today.
Apyx Medical (NASDAQ:APYX) stock moved upwards by 27.6% to $1.41. The market value of their outstanding shares is at $53.2 million. The company's, Q1 earnings came out 3 days ago.
Celularity (NASDAQ:CELU) stock moved upwards by 27.57% to $1.94. The company's market cap stands at $46.1 million. The company's, Q4 earnings came out 3 days ago.

Losers

Polyrizon (NASDAQ:PLRZ) stock decreased by 91.4% to $0.03 during Tuesday's regular session.
Zhengye Biotechnology (NASDAQ:ZYBT) shares declined by 64.03% to $4.83. The market value of their outstanding shares is at $228.9 million.
Accelerate Diagnostics (NASDAQ:AXDX) stock fell 38.48% to $0.08. The company's market cap stands at $2.0 million.
Regencell Bioscience (NASDAQ:RGC) stock decreased by 38.31% to $290.0. The company's market cap stands at $3.7 billion.
Sangamo Therapeutics (NASDAQ:SGMO) stock fell 36.51% to $0.47. The market value of their outstanding shares is at $106.5 million. As per the press release, Q1 earnings came out yesterday.
Halozyme Therapeutics (NASDAQ:HALO) stock decreased by 25.95% to $49.31. The market value of their outstanding shares is at $6.0 billion. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

FAQ

Fee Schedule Open Account Deposit & Withdrawal Trading

Terms & Conditions

Client Agreement Privacy Policy Data Disclaimer Security Tips

About Webull

About us Webull Promotions Contact information Announcements

Service Email : service@webull.hkBusiness Cooperation : marketinghk@webull.hk

Risk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
① During the campaign period, US stocks, US stocks short selling, US stock options, Hong Kong stocks, and A-shares trading will maintain at $0 commission, and no subscription/redemption fees for mutual fund transactions. $0 fee offer has a time limit, until further notice. For more information, please visit: https://www.webull.hk/pricing
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.

Language

English